Metformin
GLP-1 receptor agonists may protect against CRC in patients with type 2 diabetes
Glucagon-like peptide 1 receptor agonists were associated with a reduced risk for colorectal cancer among patients with type 2 diabetes, regardless of weight status, compared with other antidiabetics, according to research.
SGLT2 inhibitors ‘substantially’ reduce gout risk in patients with type 2 diabetes
SAN DIEGO — Sodium-glucose cotransporter-2 inhibition may reduce the risk for gout by as much as 40% to 60% among certain patients with type 2 diabetes treated with metformin, according to data presented at ACR Convergence 2023.
Severe anion gap metabolic acidosis in a patient with type 2 diabetes
A man aged 51 years with a history of alcohol use disorder and type 2 diabetes treated with metformin and glimepiride and alcohol presented to the hospital for a witnessed cardiac arrest at home.
Weight loss with anti-obesity medications comparable for older, younger adults
DALLAS — Older adults who received anti-obesity medications lost a similar amount of weight at 3 to 5 years as younger adults, with no increased side effects, according to research presented at ObesityWeek.
Metformin provides glycemic, neonatal benefits for women with gestational diabetes
Metformin may lengthen the time until insulin initiation, lower fasting glucose and improve neonatal outcomes for pregnant women with gestational diabetes, according to data from a randomized trial.
Beyond diabetes, metformin may prove to be a ‘wonder drug’
In the past 2 decades, metformin has become a mainstay of type 2 diabetes management and is now the recommended first-line drug for treating the disease in the United States and worldwide.
Q&A: Medication plus lifestyle strategies best for type 2 diabetes prevention
Providers should focus more on using pharmacotherapies in addition to lifestyle intervention to prevent progression from prediabetes to type 2 diabetes, according to two researchers.
Metformin may improve outcomes in diffuse large B-cell lymphoma
The addition of metformin to standard chemotherapy improved outcomes for patients with diffuse large B-cell lymphoma, according to findings presented at Society of Hematologic Oncology Annual Meeting.
Early glycemic control may not prevent beta-cell deterioration in youth-onset diabetes
Youths with type 2 diabetes who had a lower mean HbA1c shortly after diagnosis have similar long-term beta-cell deterioration as those with a higher HbA1c, according to findings published in Diabetes Care.
Hormonal treatments effective, safe for women with hidradenitis suppurativa
Hormonal treatments for hidradenitis suppurativa — particularly finasteride, spironolactone and metformin — are efficacious and safe for women, but dermatologists should be aware of treatment interactions, according to a review.